Rockwell Medical Inc Revenue Growth Rates (RMTI), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Rockwell Medical inc   (NASDAQ: RMTI)
 

RMTI's Revenue Growth by Quarter and Year

Rockwell Medical Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RMTI Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 17.78
1st Quarter March 16.90
FY 34.68

RMTIs Annual Revenue
Rockwell Medical Inc 's Revenue in the fiscal year 2025 $ 68.70 millions
Rockwell Medical Inc 's Revenue in the fiscal year 2024 $ 101.48 millions
Rockwell Medical Inc 's Revenue in the fiscal year 2023 $ 83.61 millions
Rockwell Medical Inc 's Revenue in the fiscal year 2022 $ 72.08 millions
Rockwell Medical Inc 's Revenue in the fiscal year 2021 $ 61.58 millions




RMTI Revenue second quarter 2026 Y/Y Growth Comment
Rockwell Medical inc achieved in the second quarter 2026, above Company average Revenue increase of 14.71% year on year, to $ 17.78 millions.

Looking into second quarter 2026 results within Major Pharmaceutical Preparations industry 95 other companies have achieved higher Revenue growth. While Rockwell Medical Inc ' s Revenue growth of 14.71% ranks overall at the positon no. 1310 in the second quarter 2026.


RMTI Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - -22.43 % 16.03 % 14.4 %
3rd Quarter September - -45.93 % 21.72 % 30.48 %
2nd Quarter June 14.71 % -39.33 % 41.71 % 1.58 %
1st Quarter March -6.32 % -18.22 % 12.55 % 28.86 %
FY   - -32.31 % 22.38 % -

Financial Statements
Rockwell Medical Inc 's second quarter 2026 Revenue $ 17.78 millions RMTI's Income Statement
Rockwell Medical Inc 's second quarter 2025 Revenue $ 15.50 millions Quarterly RMTI's Income Statement


RMTI Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 30.19 % -9.24 % -4.78 %
3rd Quarter September - -1.48 % 10.53 % 28.67 %
2nd Quarter June 5.21 % -14.08 % 15.82 % -8.01 %
1st Quarter March -14.99 % -29.61 % -0.14 % 1.5 %
FY (Year on Year)   - -32.31 % 22.38 % -


Back to RMTI Growth rate Comparisons >> Back to RMTI Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #96
Healthcare Sector #235
Overall #1310

Revenue Y/Y Growth Statistics
High Average Low
41.68 % 2.73 % -45.92 %
(Jun 30 2024)   (Dec 31 2025)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #96
Healthcare Sector #235
Overall #1310
Revenue Y/Y Growth Statistics
High Average Low
41.68 % 2.73 % -45.92 %
(Jun 30 2024)   (Dec 31 2025)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Rockwell Medical Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
30.16 % 0.8 % -29.61 %
(Dec 31 2025)  


RMTI's II. Quarter Q/Q Revenue Comment
Rockwell Medical inc achieved in the II. Quarter 2026 above company average sequential Revenue increase of 5.21%, to $ 17.78 millions, from $16.90 millions in the first quarter.
RMTI is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Major Pharmaceutical Preparations industry 68 other companies have achieved higher Revenue quarter on quarter growth. While Rockwell Medical Inc 's Revenue growth quarter on quarter, overall rank is 1118.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #69
Healthcare Sector #163
Overall #1118
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #69
Healthcare Sector #163
Overall #1118
Revenue Q/Q Growth Statistics
High Average Low
30.16 % 0.8 % -29.61 %
(Dec 31 2025)  


RMTI's II. Quarter Q/Q Revenue Comment
Rockwell Medical inc achieved in the II. Quarter 2026 above company average sequential Revenue increase of 5.21%, to $ 17.78 millions, from $16.90 millions in the first quarter.
RMTI is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Major Pharmaceutical Preparations industry 68 other companies have achieved higher Revenue quarter on quarter growth. While Rockwell Medical Inc 's Revenue growth quarter on quarter, overall rank is 1118.


Rockwell Medical Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 69.83 $ 67.55 $ 68.70 $ 74.45 $ 87.42
Y / Y Revenue Growth (TTM) -20.12 % -30.69 % -32.31 % -23.99 % -5.91 %
Year on Year Revenue Growth Overall Ranking # 2990 # 1053 # 425 # 372 # 553
Seqeuential Revenue Change (TTM) 3.37 % -1.67 % -7.73 % -14.83 % -10.31 %
Seq. Revenue Growth (TTM) Overall Ranking # 3211 # 2746 # 1948 # 1107 # 1311


Cumulative Revenue growth Comment
Rockwell Medical Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Rockwell Medical Inc 's annual Revenue decrease would be -20.12% year on year to $70 millions.

In the Healthcare sector 412 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1053 to 2990.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 136
Healthcare Sector # 413
Overall # 2990

Revenue TTM Y/Y Growth Statistics
High Average Low
24.34 %
 2.97 %
-32.31 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 136
Sector # 425
S&P 500 # 3211
Cumulative Revenue growth Comment
Rockwell Medical Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Rockwell Medical Inc 's annual Revenue drop would be -20.12% year on year to $70 millions.

In the Healthcare sector 412 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1053 to 2990.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 136
Healthcare Sector # 413
Overall # 2990

Revenue TTM Y/Y Growth Statistics
High Average Low
24.34 %
2.97 %
-32.31 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 136
Sector # 425
S&P 500 # 3211




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RMTI's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Grail Inc 25.72%$ 25.723 millions
Fortress Biotech Inc 25.66%$ 25.658 millions
Apyx Medical Corp25.27%$ 25.273 millions
Radnet Inc 24.99%$ 24.986 millions
Precipio inc 24.18%$ 24.178 millions
Krystal Biotech Inc 24.14%$ 24.135 millions
Viemed Healthcare Inc 23.85%$ 23.853 millions
Ardelyx inc 23.77%$ 23.771 millions
Insulet Corporation23.51%$ 23.509 millions
Veracyte Inc 23.45%$ 23.448 millions
Journey Medical Corp23.33%$ 23.326 millions
Twist Bioscience Corporation23.24%$ 23.235 millions
Axogen inc 23.06%$ 23.065 millions
Vericel Corporation22.48%$ 22.481 millions
Milestone Scientific Inc 22.28%$ 22.276 millions
Alpha Teknova Inc 22.05%$ 22.045 millions
X4 Pharmaceuticals Inc21.64%$ 21.642 millions
Exagen Inc 21.63%$ 21.629 millions
Adaptive Biotechnologies Corporation21.53%$ 21.526 millions
Privia Health Group Inc 21.39%$ 21.390 millions
Bionano Genomics Inc 21.36%$ 21.357 millions
Evolus Inc 21.30%$ 21.298 millions
Invivyd Inc 21.20%$ 21.203 millions
Transmedics Group Inc 20.70%$ 20.702 millions
Irhythm Holdings Inc 20.62%$ 20.615 millions
Delcath Systems Inc 20.60%$ 20.604 millions
Castle Biosciences Inc 20.14%$ 20.140 millions
Procept Biorobotics Corporation20.00%$ 20.004 millions
Biomarin Pharmaceutical Inc19.91%$ 19.905 millions
Cannapharmarx Inc 19.26%$ 19.261 millions


About Rockwell Medical Inc Revenue Growth Rates (RMTI), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Rockwell Medical Inc (CIK 1041024).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-056461
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Rockwell Medical Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.